Pharmaceuticals
Healthcare
ChrysCapital invests in Gujarat-based pharma player La Renon Healthcare
Homegrown private equity player ChrysCapital has widened its healthcare portfolio in the country with a $70 million (Rs 585 crore) ......
Healthcare
KKR-controlled JB Chemicals draws interest from PE firms, drugmakers
A clutch of suitors including pharmaceutical companies and bulge-bracket private equity firms have shown interest in picking up a majority ......
Healthcare
ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business
Eris Lifesciences, a Mumbai-based listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, is to acquire ......
Healthcare
Advent to merge Cohance, Suven in share-swap deal
Advent International, a global private equity firm, Thursday announced the plan to merge two of its pharmaceutical portfolio companies, Cohance ......
Healthcare
Former Biocon execs' CRAMS firm Anthem Bio eyes pre-IPO funding
Bengaluru-based pharma contract research company Anthem Biosciences Pvt. Ltd, which hit the billion-dollar valuation mark two years ago after private ......
Healthcare
ChrysCapital-backed Eris Life acquires controlling stake in Swiss Parenterals for $77 mn
Listed pharmaceuticals player Eris Lifesciences Ltd has acquired 51% stake in sterile injectables company Swiss Parenterals for Rs 637.5 crore ......
Healthcare
Manipal Hospitals backer Novo Holdings to invest $35 bn over next six years
Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, plans to invest about $35 billion by 2030, CEO ......
Healthcare
Bottomline: Affirma-backed nutraceuticals maker Tirupati's financial see-saw continues
Nutraceuticals maker Tirupati Medicare recorded a hit in operational margin in FY23 after fluctuations last fiscal, even as the company’s ......
Healthcare
Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?
Homegrown corticosteroid and hormones API-maker Symbiotec Lifesciences Pvt. Ltd’s revenue and profitability took a hit in FY23, even as the ......
Healthcare
Kotak's second special situations PE fund bankrolling big-ticket pharma acquisition
Kotak Alternate Asset Managers (previously Kotak Investment Advisors), the alternative investment arm of Kotak Group, which hit a first close of ......